Eli Lilly

Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds. These and similar drugs have continuously experienced shortages since their debut in recent years, with demand far outstripping supply.An AI That Helps You Get a Job? | AI UnlockedThe 30-second reverse…

The 46-year-old Voyager 1 spacecraft is on the fritz again, and this time it may be critical. As one engineer said, “this is, by far, the most serious since I’ve been project manager.” Here are our top science stories from this week.Read more... The 46-year-old Voyager 1 spacecraft is on the fritz again, and this time it may be critical. As one engineer said, “this is, by far, the most serious since I’ve been project manager.” Here are our top science stories from this week.Read more... FOLLOW US ON GOOGLE NEWS…

The newest obesity drug on the market, Eli Lilly’s tirzepatide, may also help keep people’s blood pressure in check, new research out Monday has shown. The study looked at clinical trial participants and found that people taking it experienced a drop in their systolic blood pressure on average compared to a placebo group over a six-month span. The research is the latest to indicate that a new group of obesity drugs can offer health benefits beyond weight loss.Alex Winter on Innovative Horror Movies Tirzepatide, developed…

A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the medication. More than a third of former users did substantially regain much or all of their original weight, however.Alex Winter on the Most Important Modern Horror Movie Semaglutide mimics the natural GLP-1…

Another year, another round of inscrutable price increases for many prescription drugs. Over 700 medicines are seeing their list prices shoot up this January, according to an analysis by the organization 46brooklyn Research. The average price increase is slightly below the trend of recent years, but includes popular drugs used for weight loss like Ozempic and Mounjaro.Remake this Sci-Fi Film with Peter Capaldi!The Ohio-based 46brooklyn is a nonprofit corporation that describes its purpose as seeking “to improve the…

A popular class of weight loss and diabetes drugs looks to be safer than feared, at least so far. This week, the Food and Drug Administration announced it hasn’t found compelling evidence that Wegovy, Ozempic, and other GLP-1 drugs can cause suicidal thoughts or behaviors—a concern that first emerged last year. The FDA hasn’t definitively ruled out a possible connection just yet, however, and it is still conducting further investigation into the matter.Would Peter Capaldi Return to Doctor Who?In summer 2023, health…

Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion. Isomorphic will receive $45 million upfront from Eli Lilly and potentially up to $1.7 billion based on performance milestones, excluding royalties. Novartis,…

Wegovy and similar weight loss drugs may cause more side effects than currently recognized. The Food and Drug Administration is now looking into whether these new generation obesity drugs can trigger hair loss, suicide ideation, and food aspiration, based on adverse event reports linked to their use. These reports are only intended to be a potential warning signal and do not prove causation, but the FDA could take further regulatory action should their investigation bear fruit, such as modifying the drugs’ labeling.Let’s…

Few prescription drugs have entered the public consciousness as abruptly as Ozempic and Wegovy have in recent years. Novo Nordisk’s brand-name medications have become as synonymous with weight loss as Viagra and Cialis are with erectile dysfunction. But while 2023 has made it clear that these and similar drugs really are the future of obesity treatment, it’s also shown that this future looks plenty messy—sometimes for reasons that have little to do with the drugs themselves.Let’s Eat a Chocolate Xbox…

Journal Reports: LeadershipWhat’s New in the Best Managed Companies Rankings in 2023By Rick Wartzman , and Kelly TangDecember 13, 2023 at 1:02 PM ETThe main difference: a new metric that measures how well companies foster career mobility. Journal Reports: LeadershipWhat’s New in the Best Managed Companies Rankings in 2023By Rick Wartzman , and Kelly TangDecember 13, 2023 at 1:02 PM ETThe main difference: a new metric that measures how well companies foster career mobility. FOLLOW US ON GOOGLE NEWS Read original…